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A 54-year-old woman was admitted with compression fracture of thoracic vertebral bodies. Urine protein electro-
phoresis revealed the presence of M protein and serum free κ/λ ratio was 0.01. Bone marrow aspiration (A) and 
biopsy (B) r ev eal ed  d if f u se  in f ilt r at io n  o f  n ume ro u s l arg e-size d b las t s wit h  baso p h il ic cyt o p las m, d ispe rse d n u cl ear 
chromatin, high nuclear/cytoplasmic ratio and prominent nucleoli. Tumor cells showed strong expression of plasma 
cell (PC) antigen CD138 (C), monotypic light chain (D, κ negative; E, λ positive), negative expression of CD3, CD20, 
CD34, Tdt and CD30 by immunohistochemistry, mimicking a picture of plasmablastic lymphoma (PBL). PBL was ex-
cluded on the basis of CD56 positivity (F) and absence of EBV-encoded RNA (G). The diagnosis of plasmablastic 
plasma cell myeloma (PBPCM) was made and the patient started chemotherapy. Morphologic features usually distin-
guish PBL from well-differentiated plasma cell myeloma (PCM). However, highly aggressive PBPCM may show pre-
dominance of plasma blasts, which can resemble PBL cells. Although both PB myeloma and PBL express PC antigens 
(CD138, monotypic light chain), positivity of EBV-encoded RNA is useful in establishing the diagnosis of PBL.